Diagnostic Evaluation and Management of Acoustic Neuroma
Clinical Presentation and Diagnosis
- Unilateral sensorineural hearing loss is present in up to 94% of cases, tinnitus in up to 83% of cases, and vestibular symptoms including vertigo and unsteadiness in 17-75% of cases, with large tumors potentially presenting with trigeminal and facial neuropathies, brainstem compression, or hydrocephalus 1
- The diagnostic yield of MRI for vestibular schwannoma in patients with asymmetric sensorineural hearing loss is higher when there is ≥10 dB of interaural difference at 2 or more contiguous frequencies or ≥15 dB at 1 frequency, with MRI recommended for patients with sudden sensorineural hearing loss, though the diagnostic yield for vestibular schwannoma is relatively low (<3%) 2
Imaging Modalities and Protocols
- MRI with dedicated internal auditory canal protocol is the gold standard for initial workup, including standard T1 and T2-weighted sequences, T1-weighted sequences before and after gadolinium administration, thin slice spin echo or turbo spin echo T1-weighted sequences, axial submillimetric heavily T2-weighted sequences, and diffusion-weighted imaging (DWI) to differentiate VS from arachnoid or epidermoid cysts, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 3, 1
- CT scanning of the head/brain is strongly discouraged as an initial evaluation due to poor resolution for detecting acoustic neuromas, especially small ones, and exposure to radiation, while CT temporal bone with contrast may provide complementary information for preoperative surgical planning, although it should be considered when MRI is contraindicated 3, 1, 4
- The optimal MRI protocol for post-surgical follow-up should include T1-weighted sequences before and after gadolinium administration, T2-weighted sequences, diffusion-weighted imaging (DWI), axial submillimetric heavily T2-weighted sequences, fluid-attenuated inversion recovery sequences, thin slice spin echo or turbo spin echo/fast spin echo T1-weighted sequences, and submillimetric T1-weighted 3D gradient echo sequences, as recommended by the guideline society 1
Diagnostic Yield and Audiometry
- Audiometry is used to document the degree and type of hearing loss, while Auditory Brainstem Response (ABR) may be considered but has limitations, including missing up to 20% of intracanalicular vestibular schwannomas and being more sensitive for tumors >1 cm in size 4
- Incidental findings on MRI are common, with 57% of MRI studies in patients with sudden sensorineural hearing loss showing some abnormality, although only 11% of these findings are directly related to the hearing loss, highlighting the importance of careful interpretation of results 4
Post-Surgical Follow-Up and Screening
- Transient increase in tumor size may occur within the first year due to radiation effect, not tumor growth, and serial imaging is essential to distinguish stable postoperative changes from growing residual tumor 1
- Neurofibromatosis Type 2 (NF2) screening should be considered when a patient presents with unilateral vestibular schwannoma at <30 years, as bilateral vestibular schwannomas are a hallmark of NF2, with a strength of evidence supporting this recommendation 1
- A more aggressive follow-up schedule may be needed, with MRIs every 6 months for the first 2 years, and consideration of screening family members, particularly in cases of Neurofibromatosis Type 2 (NF2) 1
- The first MRI is recommended at 6-12 months post-surgery, with subsequent scans at regular intervals based on surgical approach and extent of resection, with possible follow-up schedules including MRIs every 1-2 years for 5 years, and then every 2-3 years if stable, or annually for 5 years, and then every 1-2 years, due to a higher vigilance for recurrence 1